Even before graduating from medical school, Dr. Chase Feiger cofounded a company, which has raised more than $130 million in funding, to create globally distributed software solutions across pharma, diagnostics, med device, CPG and other industrial environments. Feiger also spent years as a VC, investing in more than 20 companies across healthcare, pharma, diagnostics, AI, deeptech and more. Ultimately, he decided the most profound way he could influence the healthcare industry was through designing software solutions for HCPs and patients, with a primary focus on healthcare marketing. That vision led him to cofound Ostro in 2019 and become its CEO.

Ostro partners with top pharma brands and agencies to create AI/large language model (LLM) and data-driven commercial-based software solutions. The company has raised more than $56 million in funding from prominent investors and Feiger has helped lead its more than 250% year-over-year top-line revenue growth in 2022.

In addition to leading Ostro, Feiger is an avid writer, regularly covering topics regarding innovation and pharma commercialization for Forbes.

‍